Carbohydrates

Medchemexpress LLC N-(benzyloxycarbonyl)-D-leucine | 28862-79-5 | MFCD00066068 | 99.1% | 265.30 g/mol | C14H19NO4 | 100g

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

D-N-(Benzyloxycarbonyl)leucine is a leucine derivative[1]

Medchemexpress LLC D-Galactose pentaace 50g

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

D-Galactose pentaacetate inhibits leucine-induced insulin release D-Galactose pentaacetate can be used for the research of persistent hyperinsulinemia in childhood or insulinoma[1][2]

Medchemexpress LLC D-Galactose pentaace 10g

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

D-Galactose pentaacetate inhibits leucine-induced insulin release D-Galactose pentaacetate can be used for the research of persistent hyperinsulinemia in childhood or insulinoma[1][2]

Medchemexpress LLC D-Galactose pentaace 5g

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

D-Galactose pentaacetate inhibits leucine-induced insulin release D-Galactose pentaacetate can be used for the research of persistent hyperinsulinemia in childhood or insulinoma[1][2]

Medchemexpress LLC D-Galactose pentaace 100g

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

D-Galactose pentaacetate inhibits leucine-induced insulin release D-Galactose pentaacetate can be used for the research of persistent hyperinsulinemia in childhood or insulinoma[1][2]

Medchemexpress LLC D-Galactose pentaace 25g

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

D-Galactose pentaacetate inhibits leucine-induced insulin release D-Galactose pentaacetate can be used for the research of persistent hyperinsulinemia in childhood or insulinoma[1][2]

Medchemexpress LLC β-D-galactose pentaacetate | 4163-60-4 | MFCD00063259 | 99.6% | 390.34 g·mol-1 | C16H22O11 | 250 G

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

β-D-galactose pentaacetate is the β-anomer of D-galactose with five acetylated hydroxyl groups. It functions as an insulin antagonist, penetrates the plasma membrane, and is hydrolyzed by intracellular esterases; it inhibits leucine-induced insulin release in Wistar rat islets. Supplied as a solid or as pre-made DMSO solutions for research use.

• High purity (≈99.6%).
• Molecular weight 390.34 g·mol-1.
• Cell-permeable acetylated sugar cleaved by intracellular esterases.
• Available as solid and ready-to-use DMSO solutions.
• White to off-white solid appearance.
• Store solid at 4°C under nitrogen and protect from moisture.